DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

LinksClose Window

References

NHS National Institute for Health and Clinical Excellence.
Technology Appraisal Guidance 91 Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer. 2005 [cited 2012 September 7].

http://www.nice.org.uk/TA091 Stand: 07.09.2012

Download Bibliographical Data

Search in:

We do not assume any responsibility for the contents of the web pages of other providers.